Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
All LSBio Custom kits have been predesigned and all necessary components, including antibodies and standards have been identified. Upon receiving a custom kit order, the kit will be assembled and quality control tested before being shipped out. Kit assembly and testing typically takes 4 to 6 weeks. In most cases the final kit is based on the Sandwich assay principle, with a few being Competitive EIA based. Specifications such as Range, Sensitivity, and Precision are defined upon completion. In the event that the custom kit cannot be successfully developed with 6 weeks of the order date, the customer will be notified and the order canceled at no cost.
F8 / FVIII / Factor VIII
LS-F42450 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of Monkey F8 / FVIII / Factor VIII. It is based upon a Custom assay principle and can be used to detect levels of F8 / FVIII / Factor VIII as low as 0.188 nanograms per millilter.
F8 ElisaKit, AHF ElisaKit, Antihemophilic factor ElisaKit, Coagulation factor VIIIc ElisaKit, Coagulation factor VIII ElisaKit, DXS1253E ElisaKit, Factor VIII F8B ElisaKit, FVIII ElisaKit, HEMA ElisaKit, F8B ElisaKit, Factor VIII ElisaKit, Procoagulant component ElisaKit, F8C ElisaKit
F8 / FVIII / Factor VIII is coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex.